Drug Discov Today. 2003 Jan 15;8(2):86-96.

Nonleadlikeness and leadlikeness in biochemical screening.

Source

Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA. grishton@amgen.com

Abstract

Biochemical assays have largely supplanted functional biological assays as drug screening tools in the early stages of drug discovery. The de-selection of compounds that are 'nonleadlike' binders (and bonders) and the proactive selection of those compounds that are 'leadlike' in their binding to the target are vital components of the screening effort. The physiochemical properties of leadlikeness and the surprising differences between those properties and the now classical definitions of druglikeness are becoming apparent.

Comment in

Drug Discov Today. 2003 Apr 1;8(7):292-3.

PMID:: 12565011; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Related citations

Review Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening. [Curr Opin Chem Biol. 2008]
Review Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening.
Rishton GM. Curr Opin Chem Biol. 2008 Jun; 12(3):340-51. Epub 2008 Mar 25.
Leadlikeness and structural diversity of synthetic screening libraries. [Mol Divers. 2006]
Leadlikeness and structural diversity of synthetic screening libraries.
Verheij HJ. Mol Divers. 2006 Aug; 10(3):377-88. Epub 2006 Sep 21.
Review Use of high-content analysis for compound screening and target selection. [IDrugs. 2005]
Review Use of high-content analysis for compound screening and target selection.
Rausch O. IDrugs. 2005 Jul; 8(7):573-7.
Review Multivariate pharmaceutical profiling for drug discovery. [Curr Top Med Chem. 2002]
Review Multivariate pharmaceutical profiling for drug discovery.
Kerns EH, Di L. Curr Top Med Chem. 2002 Jan; 2(1):87-98.
Review Failure and success in modern drug discovery: guiding principles in the establishment of high probability of success drug discovery organizations. [Med Chem. 2005]
Review Failure and success in modern drug discovery: guiding principles in the establishment of high probability of success drug discovery organizations.
Rishton GM. Med Chem. 2005 Sep; 1(5):519-27.

See reviews... See all...

Cited by 18 PubMed Central articles

Automated reporter quantification in vivo: high-throughput screening method for reporter-based assays in zebrafish. [PLoS One. 2012]
Automated reporter quantification in vivo: high-throughput screening method for reporter-based assays in zebrafish.
Walker SL, Ariga J, Mathias JR, Coothankandaswamy V, Xie X, Distel M, Köster RW, Parsons MJ, Bhalla KN, Saxena MT, et al. PLoS One. 2012; 7(1):e29916. Epub 2012 Jan 4.
Development and validation of a yeast high-throughput screen for inhibitors of Aβ₄₂ oligomerization. [Dis Model Mech. 2011]
Development and validation of a yeast high-throughput screen for inhibitors of Aβ₄₂ oligomerization.
Park SK, Pegan SD, Mesecar AD, Jungbauer LM, LaDu MJ, Liebman SW. Dis Model Mech. 2011 Nov; 4(6):822-31. Epub 2011 Aug 2.
Mining a cathepsin inhibitor library for new antiparasitic drug leads. [PLoS Negl Trop Dis. 2011]
Mining a cathepsin inhibitor library for new antiparasitic drug leads.
Ang KK, Ratnam J, Gut J, Legac J, Hansell E, Mackey ZB, Skrzypczynska KM, Debnath A, Engel JC, Rosenthal PJ, et al. PLoS Negl Trop Dis. 2011 May 3; 5(5):e1023. Epub 2011 May 3.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Nonleadlikeness and leadlikeness in biochemical screening.
Nonleadlikeness and leadlikeness in biochemical screening.
Drug Discov Today. 2003 Jan 15 ;8(2):86-96.

PubMed
Molecular diversity in the context of leadlikeness: compound properties that ena...
Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening.
Curr Opin Chem Biol. 2008 Jun ;12(3):340-51. Epub 2008 Mar 25 .

PubMed
The placental transfer and toxicity of selenite relative to cadmium in the human...
The placental transfer and toxicity of selenite relative to cadmium in the human term perfused placenta.
Placenta. 1994 Dec ;15(8):883-95.

PubMed
Complementary and alternative medicine use by primary care patients with chronic...
Complementary and alternative medicine use by primary care patients with chronic pain.
Pain Med. 2008 Nov ;9(8):1065-72. Epub 2008 Jun 18 .

PubMed
Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and tim...
Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus: a paired liver biopsy study.
J Hepatol. 2007 Apr ;46(4):613-9. Epub 2007 Jan 26 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: